American Red Cross Blood Services Research Articles

Frequency of platelet associated antibodies in sera from refractory patients : L. Meredith; American Red Cross Blood Services, Atlanta, GA

Frequency of platelet associated antibodies in sera from refractory patients : L. Meredith; American Red Cross Blood Services, Atlanta, GA

Inhibition of human lymphocyte proliferation by UV-B Irradiated cells and soluble suppressor factors : B. Duffy, L. Sherman, and G. Rodey; American Red Cross Blood Services, Dept. of Pathology, Washington University School of Medicine, St. Louis, MO

Inhibition of human lymphocyte proliferation by UV-B Irradiated cells and soluble suppressor factors : B. Duffy, L. Sherman, and G. Rodey; American Red Cross Blood Services, Dept. of Pathology, Washington University School of Medicine, St. Louis, MO

Use of two platelet cross-match techniques to select compatible platelet donors for patients refractory to HLA matched donors : Patricia McGrath, Nancy Tremel, Ted Eastlund, and Anthony Britten; American Red Cross Blood Services, Northeastern New York Region, Albany, NY

Use of two platelet cross-match techniques to select compatible platelet donors for patients refractory to HLA matched donors : Patricia McGrath, Nancy Tremel, Ted Eastlund, and Anthony Britten; American Red Cross Blood Services, Northeastern New York Region, Albany, NY

Growth and characterization of human monocytes (macrophages) : A. Nikaein and K. McQueen; University of Rochester and American Red Cross Blood Services, Rochester Region, Rochester, NY

Growth and characterization of human monocytes (macrophages) : A. Nikaein and K. McQueen; University of Rochester and American Red Cross Blood Services, Rochester Region, Rochester, NY

HLA antibody laden plasma implicated in a transfusion reaction : Patricia McGrath, Carol Duma, Richard Propp, Ted Eastlund, and Anthony Britten; American Red Cross Blood Services, Northeastern New York Region, Albany, NY

HLA antibody laden plasma implicated in a transfusion reaction : Patricia McGrath, Carol Duma, Richard Propp, Ted Eastlund, and Anthony Britten; American Red Cross Blood Services, Northeastern New York Region, Albany, NY

HLA and IgA deficiency in blood donors : Rosemarie Strothman, Jeffrey Testin, Sanking N. Chen, and Margaret J. Ball; American Red Cross Blood Services, Fort Wayne, IN

HLA and IgA deficiency in blood donors : Rosemarie Strothman, Jeffrey Testin, Sanking N. Chen, and Margaret J. Ball; American Red Cross Blood Services, Fort Wayne, IN

Serological analysis of Aw33, w34, w34∗, B35, w53, 5Y(8w58) from a family study : Patricia McGrath, Carol Duma, Maryanne Mackin, Edward Rainka, William Scharfman, Ted Eastlund, and Anthony Britten; American Red Cross Blood Services, Northeastern New York Region, Albany, NY

Serological analysis of Aw33, w34, w34∗, B35, w53, 5Y(8w58) from a family study : Patricia McGrath, Carol Duma, Maryanne Mackin, Edward Rainka, William Scharfman, Ted Eastlund, and Anthony Britten; American Red Cross Blood Services, Northeastern New York Region, Albany, NY

American Red Cross Blood Services Directive 4.47--therapeutic apheresis.

American Red Cross Blood Services Directive 4.47--therapeutic apheresis.

Proficiency in Testing for Hepatitis B Surface Antigen: Experience with Ausria II®1

Eight hepatitis B surface antigen (HBsAg) proficiency panels were tested using a radioimmunoassay (RIA) test kit during 1978 and 1979 by routine processing laboratories within the 57 American Red Cross Blood Services Regions. The test results were analyzed and it was found that lot-to-lot variability in the reagents may result in a measurable loss of sensitivity of the test leading to an increased error rate. On the basis of these studies, it is recommended that the positive to negative (P/N) ratio for validation of the test be raised to at least 25.

Proficiency in Testing for Hepatitis B Surface Antigen: Experience with Ausria II®1

AbstractEight hepatitis B surface antigen (HBsAg) proficiency panels were tested using a radioimmunoassay (RIA) test kit during 1978 and 1979 by routine processing laboratories within the 57 American Red Cross Blood Services Regions. The test results were analyzed and it was found that lot‐to‐lot variability in the reagents may result in a measurable loss of sensitivity of the test leading to an increased error rate. On the basis of these studies, it is recommended that the positive to negative (P/N) ratio for validation of the test be raised to at least 25.

Proficiency in Testing for Hepatitis B Surface Antigen: Experience with Ausria II®

Eight hepatitis B surface antigen (HBsAg) proficiency panels were tested using a radioimmunoassay (RIA) test kit during 1978 and 1979 by routine processing laboratories within the 57 American Red Cross Blood Services Regions. The test results were analyzed and it was found that lot-to-lot variability in the reagents may result in a measurable loss of sensitivity of the test leading to an increased error rate. On the basis of these studies, it is recommended that the positive to negative (P/N) ratio for validation of the test be raised to at least 25.

The demonstration of two distinct public specificities on HLA-A28 bearing cells: [formula omitted]. American Red Cross Blood Services, Missouri-Illinois Region, St. Louis, MO

The demonstration of two distinct public specificities on HLA-A28 bearing cells: [formula omitted]. American Red Cross Blood Services, Missouri-Illinois Region, St. Louis, MO

The occurrence of BW6-associated HLA-B37 phenotypes: [formula omitted] and [formula omitted]. American Red Cross Blood Services, Missouri-Illinois Region and Div. Lab. Med., Washington University School of Medicine, St. Louis, MO.

The occurrence of BW6-associated HLA-B37 phenotypes: [formula omitted] and [formula omitted]. American Red Cross Blood Services, Missouri-Illinois Region and Div. Lab. Med., Washington University School of Medicine, St. Louis, MO.

Evidence of further heterogeneity of the A9 antigen a serological study in Caucasians and American Indians: [formula omitted], American Red Cross Blood Services, Badger Regon, Madison, Wisconsin

Evidence of further heterogeneity of the A9 antigen a serological study in Caucasians and American Indians: [formula omitted], American Red Cross Blood Services, Badger Regon, Madison, Wisconsin

Which Are the Principal Established or Potential Risks for Donors Undergoing Cytapheresis Procedures and How Can They Be Prevented?1

Vox SanguinisVolume 39, Issue 3 p. 169-179 Which Are the Principal Established or Potential Risks for Donors Undergoing Cytapheresis Procedures and How Can They Be Prevented?1 Dr. H. Borberg, Dr. H. Borberg Medizinische Universitätsklinik, Joseph-Stelzmann-Strasse 9, D-5000 Köln-Lindenthal (FRG)Search for more papers by this authorMiriam B. Dahlke MD, Miriam B. Dahlke MD Medical Director, American Red Cross Blood Services, 23rd & Chestnut Streets, Philadelphia, PA 19103 (USA)Search for more papers by this authorDr. I. D. Fraser, Dr. I. D. Fraser Regional Transfusion Centre, Bristol (England)Search for more papers by this authorJ. C. Fratantoni MD, J. C. Fratantoni MD Division of Blood and Blood Products, Bureau of Biologics, Food and Drug Administration, Bethesda, MD 20205 (USA)Search for more papers by this authorJ. E. French PhD, J. E. French PhD Division of Blood and Blood Products, Bureau of Biologics, Food and Drug Administration, Bethesda, MD 20205 (USA)Search for more papers by this authorPaul V. Holland MD, Paul V. Holland MD Clinical Center Blood Bank, NIH, Bethesda, MD 20205 (USA)Search for more papers by this authorHarvey G. Klein MD, Harvey G. Klein MD Clinical Center Blood Bank, NIH, Bethesda, MD 20205 (USA)Search for more papers by this authorH. F. Polesky MD, H. F. Polesky MD The Minneapolis War Memorial Blood Bank, 2304 Park Avenue, Minneapolis, MN 55404 (USA)Search for more papers by this authorS. Gerald Sandler MD, S. Gerald Sandler MD Associate Director, Blood Services, Headquarters, American Red Cross, Washington, DC 20006 (USA)Search for more papers by this author Dr. H. Borberg, Dr. H. Borberg Medizinische Universitätsklinik, Joseph-Stelzmann-Strasse 9, D-5000 Köln-Lindenthal (FRG)Search for more papers by this authorMiriam B. Dahlke MD, Miriam B. Dahlke MD Medical Director, American Red Cross Blood Services, 23rd & Chestnut Streets, Philadelphia, PA 19103 (USA)Search for more papers by this authorDr. I. D. Fraser, Dr. I. D. Fraser Regional Transfusion Centre, Bristol (England)Search for more papers by this authorJ. C. Fratantoni MD, J. C. Fratantoni MD Division of Blood and Blood Products, Bureau of Biologics, Food and Drug Administration, Bethesda, MD 20205 (USA)Search for more papers by this authorJ. E. French PhD, J. E. French PhD Division of Blood and Blood Products, Bureau of Biologics, Food and Drug Administration, Bethesda, MD 20205 (USA)Search for more papers by this authorPaul V. Holland MD, Paul V. Holland MD Clinical Center Blood Bank, NIH, Bethesda, MD 20205 (USA)Search for more papers by this authorHarvey G. Klein MD, Harvey G. Klein MD Clinical Center Blood Bank, NIH, Bethesda, MD 20205 (USA)Search for more papers by this authorH. F. Polesky MD, H. F. Polesky MD The Minneapolis War Memorial Blood Bank, 2304 Park Avenue, Minneapolis, MN 55404 (USA)Search for more papers by this authorS. Gerald Sandler MD, S. Gerald Sandler MD Associate Director, Blood Services, Headquarters, American Red Cross, Washington, DC 20006 (USA)Search for more papers by this author First published: September 1980 https://doi.org/10.1111/j.1423-0410.1980.tb01853.xCitations: 1 1 Berne, June 1980. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume39, Issue3September 1980Pages 169-179 RelatedInformation

Hepatitis‐Associated Markers in the American Red Cross Volunteer Blood Donor Population

During the year 1978 this laboratory evaluated the specificity of all samples found reactive for hepatitis B surface antigen (HBsAg) by 44 of 57 regions of the American Red Cross Blood Services. Radioimmunoassay detected a total of 1.921 HBsAg-reactive sampled among more than three million donor units tested. A vast majority (96%) of the samples had high level of HBsAg (greater than or equal to 20 ng/ml). Only about 50% of the samples with low level of HBsAg (less than 20 ng/ml) were reactive in reversed passive hemagglutination. There were 13 samples that were repeatable for HBsAg but were considered nonspecific as they were nonneutralizable in radioimmunoassay, 2 donors who showed nonspecific reactivity were further tested and it was found that the reactivity in radioimmunoassay persisted for more than 9 months, and this reactivity was also detectable by a second commercial kit for HBsAg. Antibodies to core and surface antigen were not found in any of the nine samples that were tested. The explanation of this nonspecific reactivity is unclear, but the data suggest that the nonspecific factor(s) may be an inherent property of the sample rather than a deficiency of the test reagents.

In memoriam: Israel Davidsohn, 1895-1979.

Journal Article Israel Davidsohn, M.D., SC.D. 1895–1979 Get access Chang Ling Lee, M.D. Chang Ling Lee, M.D. Director Charles Hymen Blood Center of Mount Sinai Hospital Medical Center Scientific Director, American Red Cross Blood Services, Mid-American Region Professor of Medicine and Pathology, Rush Medical College Search for other works by this author on: Oxford Academic Google Scholar American Journal of Clinical Pathology, Volume 73, Issue 5, 1 May 1980, Pages 733–734, https://doi.org/10.1093/ajcp/73.5.733 Published: 01 May 1980

Hepatitis-Associated Markers in the American Red Cross Volunteer Blood Donor Population

During the year 1978 this labciatory evaluated the specificity of all samples found reactive for hepatitis B surface antigen (HBsAg) by 44 of 57 regions of the American Red Cross Blood Services. Radioimmunoassay detected a total of 1,921 HBsAg-reactive samples among more than three million donor units tested. A vast majority (96%) of the samples had high level of HBsAg (≥20 ng/ml). Only about 50% of the samples with low level of HBsAg (<20ng/ml) were reactive in reversed passive hemagglutination. There were 13 samples that were repeatably reactive for HBsAg but were considered nonspecific as they were nonneutralizable in radioimmunoassay, 2 donors who showed nonspecific reactivity were further tested and it was found that the reactivity in radioimmunoassay persisted for more than 9 months, and this reactivity was also detectable by a second commercial kit for HBsAg. Antibodies to core and surface antigen were not found in any of the nine samples that were tested. The explanation of this nonspecific reactivity is unclear, but the data suggest that the nonspecific factor(s) may be an inherent property of the sample rather than a deficiency of the test reagents.